Identifying the impact of donor-origin on the therapeutic potential of umbilical cord MSCs to attenuate lung injury in a hyperoxic rodent model of bronchopulmonary dysplasia.

C. Cyr-Depauw (Ottawa (ON), Canada), A. Vadivel (Ottawa (ON), Canada), D. Cook (Ottawa (ON), Canada), I. Mižíková (Ottawa (ON), Canada), L. Renesme (Ottawa (ON), Canada), Y. Deng (Ottawa (ON), Canada), S. Zhong (Ottawa (ON), Canada), M. Alexander Möbius (Dresden (ON), Germany), B. Thébaud (Ottawa (ON), Canada)

Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies

Session: Physiological and cellular mechanisms affecting pulmonary pathologies
Session type: E-poster session
Number: 2577

Disease area: Paediatric lung diseases, Pulmonary vascular diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Cyr-Depauw (Ottawa (ON), Canada), A. Vadivel (Ottawa (ON), Canada), D. Cook (Ottawa (ON), Canada), I. Mižíková (Ottawa (ON), Canada), L. Renesme (Ottawa (ON), Canada), Y. Deng (Ottawa (ON), Canada), S. Zhong (Ottawa (ON), Canada), M. Alexander Möbius (Dresden (ON), Germany), B. Thébaud (Ottawa (ON), Canada). Identifying the impact of donor-origin on the therapeutic potential of umbilical cord MSCs to attenuate lung injury in a hyperoxic rodent model of bronchopulmonary dysplasia.. 2577

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Apelin attenuates neonatal hyperoxic lung and heart injury in a rat model of bronchopulmonary dysplasia Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis Year: 2010
Mesenchymal stem cells prevent early inflammation in a rat model of ventilator induced lung injury Source: Annual Congress 2011 - Mechanisms of acute lung injury and mesenchymal cell treatment Year: 2011
The influence of intermittent CPAP on hyperoxic lung injury in a preterm rabbit model of bronchopulmonary dysplasia Source: International Congress 2019 – Molecular and experimental paediatric lung disease Year: 2019
Ambrisentan attenuates lung and heart injury in a rat model of bronchopulmonary dysplasia Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011
Pre-treatment with mesenchymal stem cells reduces ventilator-induced lung injury}, Source: Eur Respir J 2012; 40: 939-948 Year: 2012
Reduction of lung injury and fibrosis by human embrionic stem cells in a mouse model of silica-induced lung fibrosis Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases Year: 2011
Different effects of mesenchymal stem cells on elastase-induced pulmonary emphysema and macrophages activity in rats Source: Annual Congress 2011 - Recent developments in COPD Year: 2011
Cord blood angiogenic progenitor cells are decreased in bronchopulmonary dysplasia Source: Eur Respir J 2012; 40: 1516-1522 Year: 2012
The impact of bone marrow stem cells therapy in pulmonary and extrapulmonary acute lung injury Source: Annual Congress 2008 - Pathophysiology of acute lung injury Year: 2008
Understanding the impact of the lung microenvironment to enhance the therapeutic potential of mesenchymal stromal cells for acute respiratory distress syndrome Source: Eur Respir J, 58 (4) 2100986; 10.1183/13993003.00986-2021 Year: 2021
Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010
The use of a murine model of brain death for mechanistic studies on treatment for donor lung injury Source: Annual Congress 2011 - Improving outcomes after lung transplantation Year: 2011
Mesenchymal stem cell therapy reduces inflammation and damage in a model of chronic lung disease Source: ERS Lung Science Conference 2017 Year: 2017
Therapeutic effects of human perivascular stem cells in an emphysema mouse model Source: International Congress 2017 – From the bench: therapeutic approaches in COPD and emphysema Year: 2017
Which is the best source of mesenchymal cells to treat acute lung injury? Source: Annual Congress 2011 - Mechanisms of acute lung injury and mesenchymal cell treatment Year: 2011
Late Breaking Abstract - Enhancing the antimicrobial efficacy of mesenchymal stem cells (MSCs) to combat sepsis-induced acute lung injury (ALI) using a novel combination of immune-stimulants Source: International Congress 2017 – Late-breaking findings in pulmonary diseases Year: 2017
The new-defined mesenchymal stromal/stem cell marker has a protective role in the development of acute lung injury. Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling Year: 2019
Characterization of human mesenchymal stem cells phenotype and secretome in a in vitro model of acute lung injury inflammation Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011
Effects of hypercapnic acidosis on the primary cells relevant to ARDS pathophysiology and the therapeutic potential of mesenchymal stem cells Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury Year: 2017